SYSTEMS AND METHODS FOR EXAMINING AND TREATING INTRAPELVIC CONDITIONS
20210298589 · 2021-09-30
Inventors
Cpc classification
A61B10/04
HUMAN NECESSITIES
A61B10/0283
HUMAN NECESSITIES
A61B17/42
HUMAN NECESSITIES
A61B1/07
HUMAN NECESSITIES
International classification
A61B10/02
HUMAN NECESSITIES
Abstract
An illustrative method in accordance with the disclosure includes introducing a visualization scope having a proximal end and a distal end into a patient's uterus by way of the vagina and cervix, advancing the distal end of the visualization scope into one of the fallopian tubes from the uterus, and advancing the distal end of the visualization scope out of said fallopian tube into an abdominal cavity of the patient.
Claims
1. A diagnostic method for evaluating an intrapelvic condition, comprising: introducing a visualization scope having a proximal end and a distal end into a patient's uterus by way of the vagina and cervix; advancing the distal end of the visualization scope into one of the fallopian tubes from the uterus; and advancing the distal end of the visualization scope out of said fallopian tube into an abdominal cavity of the patient.
2. The method of claim 1, wherein the visualization scope is directed from outside the patient through the vagina, uterus, and fallopian tube into the abdominal cavity without puncturing a tissue structure.
3. The method of claim 1, further comprising: directing liquid through the visualization scope when the distal end of the visualization scope is in said fallopian tube to distend said fallopian tube; and examining at least one structure in said distended fallopian tube for an abnormality.
4. The method of claim 1, further comprising advancing the distal end of the visualization scope into a pelvic region of said abdominal cavity.
5. The method of claim 1, further comprising directing liquid through the visualization scope when the distal end of the visualization scope is in a pelvic regain of said abdominal cavity and examining at least one anatomical structure within the pelvic region of the abdominal cavity for at least one abnormality.
6. The method of claim 1, further comprising detecting at least one abnormality associated with endometriosis using the visualization scope.
7. The method of claim 1, further comprising using the visualization scope as a screening tool to detect at least one abnormality associated with cancer, and further wherein the method includes examining at least one anatomical structure selected from the group consisting of (i) a surface of the patient's uterus, (ii) at least one of the patient's ovaries, (iii) the patient's bowels, (iv) at least one of the patient's fallopian tubes, and (v) the patient's peritoneum.
8. The method of claim 1, further comprising: aspirating a fluid sample from said abdominal cavity; and performing at least one testing procedure on the fluid sample in order to detect at least one abnormality.
9. The method of claim 8, wherein the at least one testing procedure is configured to detect at least one of (i) cancerous tissue, and (ii) endometriosis.
10. The method of claim 1, wherein the visualization scope includes an electronic photodetector chip disposed proximate to the distal end of the visualization scope for receiving incoming light and a light emitting device proximate to the distal end of the visualization scope, and the method further comprises directing light onto a tissue structure and observing the tissue structure using the electronic photodetector chip.
11. The method of claim 1, further comprising tilting the pelvis of the patient in order to move the bowels out of the way of the visualization scope.
12. The method of claim 1, further comprising directing liquid into a pelvic cavity by way of the visualization scope.
13. The method of claim 1, further comprising conducting a diagnostic or treatment regimen using the visualization scope, and repeating the method a plurality times over a plurality of examinations in order to track progress of a treatment regimen of the patient.
14. The method of claim 1, further comprising directing a therapeutic agent through the visualization scope to treat tissue inside of the patient.
15. The method of claim 1, wherein the visualization scope includes an uneven outer surface configured to collect a tissue sample from a patient as the visualization scope passes over tissue of a patient.
16. The scope of claim 15, wherein the uneven outer surface includes a plurality of hair-like elements.
17. A method for evaluating an intrapelvic condition, comprising: introducing a visualization scope having a proximal end and a distal end into a patient's cul de sac; and performing at least one of a diagnostic or therapeutic procedure inside the patient's cul de sac.
18. The method of claim 17, further comprising introducing a needle through the vagina and into the cul de sac to define a passageway through which the visualization scope can pass.
19. The method of claim 17, wherein the diagnostic procedure includes at least one of aspirating fluid and obtaining a tissue sample.
20. The method of claim 17, wherein the therapeutic procedure includes delivering a beneficial agent to tissue in the cul de sac.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0019]
[0020]
[0021]
[0022]
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0023] Reference will now be made in detail to the present preferred embodiments of the disclosure, examples of which are illustrated in the accompanying drawings. The methods and corresponding steps of the disclosure will be described in conjunction with the detailed description of the system.
[0024] The devices and methods presented herein may be used for myriad purposes. Generally, the devices described herein may be used for gynecological examination purposes. But, the devices disclosed herein can similarly be used for providing diagnostic tools for examining respiratory structures such as lung bronchi and bronchioles, as well as cranial passages such as sinus passages and related structures, for example.
[0025] In accordance with one aspect of the disclosure, a scope is provided for diagnosing and/or treating an intrapelvic condition.
[0026] For purpose of explanation and illustration, and not limitation, a partial view of an illustrative embodiment of the scope 100 in accordance with the disclosure is shown in
[0027] As illustrated, scope 100 has proximal end 102 and distal end 104, and a tubular body extending from the distal end of a handle. The tubular body includes a first scope 110 operably associated therewith. As illustrated, the tubular body further defines two additional channels along its length, and includes a second scope 120 that is slidably disposed in the lumen of the tubular body. As discussed below, the second scope being configured and arranged for being advanced along a fallopian tube of a patient. A tool 130, that may be, for example, a biopsy tool, a further visualization tool, a laser catheter, or the like, can also be slidably disposed within a further lumen of the tubular body of the scope 100. If desired, the scope 120 can be a standalone device that, if desired, can be used to deliver or collect fluids from a target location inside of a patient.
[0028] The scope 100 can be (e.g., a 5 French) flexible catheter that can be provided with one or more digital light capturing devices, such as a CMOS chip (or lens and fiber optic conductor) and a light source (e.g., fiber optic or LED) at its distal tip. The CMOS can have a width, for example, of about 0.6 millimeters or greater, in any increment of 0.1 millimeters. The circuitry coupled to the CMOS chip can be coupled to electronics to convert received light signals into an image. The circuitry can be coupled to a monitor to permit real time visualization of the image received by the CMOS chip.
[0029] The scope 100 can also defines a channel along its length for fluid to be pushed and/or aspirated through the channel in addition to those illustrate in
[0030] With reference to
[0031] Regardless as to how the fluid is introduced, fluid, such as water or saline, can be directed through the visualization catheter 120 while it is gently pushed through the fallopian tube 220. This allows for selective visualization of the tube 220. Once the catheter 120 has passed through the tube 120, water or other fluid can be directed into the patient's pelvic cavity (
[0032] The surgeon or other suitable medical professional then can then examine the ovaries and pelvis underwater to detect any areas exhibiting symptoms or structures consistent with endometriosis or other disorders. Once this has been completed, some of the fluid can be aspirated back through catheter 120 and sent to cytology for analysis. This approach can therefore be used for ovarian cancer screening and to look for endometrial cells that are an indication for endometriosis. The surgeon can then visualize the other fallopian tube as well in a similar fashion.
[0033] If desired, and as illustrated in
[0034] The scopes described herein can be provided with various passageways to permit the passage of fluids therethrough for purposes of irrigation for purposes of lubrication, the cleaning of tools or equipment, for example, aspiration of fluids or cells, and/or the delivery of a beneficial agent, such as a fluid such as saline, or one or more medicaments, such as one or more pharmacological compounds and the like, and/or delivery of light or other radiation, such as a laser beam, delivering electrical energy to tissue to be treated, and the like. For purposes of illustration,
[0035] As illustrated in
[0036] The device set forth in
[0037] In accordance with further aspects, any scope set forth herein can be provided with an outer surface that has an enhanced or otherwise increased surface area that is configured to collect a tissue sample by brushing across the tissue. This can be used to obtain a tissue sample, for example, in the ovaries, fallopian tubes, cervix, uterus or abdominal cavity, for example. The enhanced surface area can be provided, for example, by providing an external sheath to the scope that includes an external layer formed, for example, of a braided hollow woven suture material. The material of the suture can in turn include a coating, if desired, to enhance its lubricity and/or its ability to collect a tissue sample. In use, this outer surface can be sent to cytology with a fluid sample from the patient. The suturing material can include small bristles, for example, to enhance their tissue collection capability.
[0038]
[0039] Thus, the disclosed methods and devices permit a complete examination of the uterus, fallopian tubes, ovaries and pelvis in the office. No general anesthesia is needed. To Applicant's knowledge, this is the first ever in office screening tool for endometriosis, first ever visual screening tool for ovarian cancer, and first ever complete in office visualization tool for the entire gynecologic reproductive system. Thus, a patient can be examined over time in the office in an outpatient procedure, for example, to see how the patient is responding to a regimen of treatment. Direct visualization can help reduce or even eliminate the need for exploratory surgery, thereby reducing the cost of care significantly, and the system can be used to deliver one or more beneficial agents (e.g., medicaments, pharmacological compounds and the like) to a target location in a patient's anatomy as set forth above.
[0040] It will be appreciated that the present disclosure also includes embodiments of methods and devices that use the above described inner visualization scope (e.g., 5 French diameter) in combination with a standard hysteroscope, wherein the standard hysteroscope defines a (e.g., 5 French diameter) channel therethrough that can be used to receive the visualization scope.
[0041] In further implementations, the systems and methods can include a further irrigation and aspiration catheter (e.g, 5 Fr diameter) that is used in the same procedure as the visualization scope to provide enhanced irrigation and suction. Such a further catheter can be used for injecting fluid into the fallopian tubes and into the peritoneal cavity and then to suction out water from the peritoneal cavity. For example, this further irrigation catheter can be introduced into the patient and into one of the patient's Fallopian tubes by inserting the catheter into a patent inside of a standard hysteroscope having a (e.g., 5 Fr) channel defined therethrough. Fluid (e.g., water, saline) can then be injected into the patient by way of the irrigation catheter. This irrigation catheter can then be removed from the outer catheter, and a visualization catheter as set forth herein can be inserted through the lumen of the outer catheter, through the Fallopian tube and into the peritoneal cavity, for example, to inspect organs or other tissue structures. Once visual inspection is complete, the visualization catheter can be withdrawn, and the irrigation catheter can be reintroduced through the outer catheter, for example, into the Fallopian tube and peritoneal cavity to aspirate or otherwise collect fluid and tissue for analysis. The visualization catheter and/or the irrigation catheter can additionally be provided with a surface configured to collect tissue samples, such as an uneven surface with ridges or bumps and depressions, structures resembling cilia or hairs on the surface, or a combination of these features. The catheter collecting the cellular specimens can then be sent to a cytology lab for analysis. The uneven collection surface can be formed, for example, by way of a surface treatment, such as embossing the surface of the catheter, by cutting depressions into it using a laser, and the like. The embossing or laser cutting of the surface (or of a portion of the inner catheter) can also act to decrease bending stiffness of the catheter, but seek to maintain hoop strength of the catheter so that the lumen of the inner catheter, if provided, does not collapse when under fluid suction, such as when a sample is being aspirated. For example an embossing or laser ablation process can form partial and/or full circumferential channels about the inner catheter that enhance bending and maintain hoop strength and also form depressions in the surface for collecting tissue samples. The resulting pattern can resemble, for example, a screw thread or helical pattern, or a pattern of indentations, as desired.
[0042] In further accordance with the disclosure, methods and devices are provided to access the recto-uterine pouch, also known by various other names (e.g., cul de sac), is the extension of the peritoneal cavity between the rectum and the posterior wall of the uterus in the female human body. It is the deepest point of the peritoneal cavity. In accordance with the present disclosure, systems and methods are provided to access and extract fluid or tissue from this anatomy. This can be particularly useful for patients with blocked fallopian tubes, or even after a hysterectomy. In an illustrative implementation, a surgeon or other suitable medical personnel can insert a needle, such as a 2 mm needle (12 gauge) having a 1.6 mm (5 French) inner diameter through the posterior of the cul de sac. The needle may be introduced by way of the vagina and puncture through the posterior cul de sac, for example, under a visualization technique such as ultrasound or the like. The visualization scope, or inner scope referenced elsewhere herein, and/or the irrigation catheter discussed elsewhere herein can then be introduced to introduce and/or collect fluid or tissue samples, and to observe tissue structures in the cul de sac and/or to deliver a beneficial agent, such as a fluid such as saline, or one or more medicaments, such as one or more pharmacological compounds and the like, and/or delivery of light or other radiation, such as a laser beam, delivering electrical energy to tissue to be treated, and the like.
[0043] The methods and devices provided by the present disclosure, as described above and shown in the drawings, provide for methods and systems for medical diagnosis and treatment with superior properties as described herein. It will be apparent to those skilled in the art that various modifications and variations can be made in the embodiments of the present disclosure described herein without departing from the spirit or scope of the disclosure. Thus, it is intended that the present disclosure include modifications and variations that are within the scope of the appended claims and their equivalents.